Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis. It binds to IL17A and acts as an immunomodulator.This drug was developed by Genentech/Roche.
List of articles in "Drug" category - Page 22
Parsatuzumab
Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.This drug was developed by Genentech/Roche.
Orticumab
Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.
Ligelizumab
Ligelizumab (INN) is a humanized monoclonal antibody that binds to IGHE. It acts as an immunomodulator.
Futuximab
Futuximab (INN) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and also binds to HER1.
Enoticumab
Enoticumab (INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.
Duligotumab
Duligotumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3.
Serinolamide A
Serinolamide A is a naturally occurring eicosanoid derivative related to anandamide which has been isolated from the marine cyanobacteria Lyngbya majuscula and related species in the Oscillatoria family. Testing established […]
Vorsetuzumab
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics designed for the treatment of cancer.Chemical names are: Immunoglobulin G1 anti-(CD antigen CD70) (human-mouse monoclonal h1F6 heavy chain) disulfide with human-mouse […]
Quisinostat
Quisinostat (USAN; development code JNJ-26481585) is an experimental drug candidate for the treatment of cancer. It is a second generation histone deacetylase inhibitor with antineoplastic activity.